# Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

> **NCT06076200** · — · RECRUITING · sponsor: **Shandong University** · enrollment: 50 (estimated)

## Conditions studied

- Early-Onset Neonatal Sepsis

## Interventions

- **DRUG:** Piperacillin Sodium and Tazobactam Sodium for Injection

## Key facts

- **NCT ID:** NCT06076200
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-30
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06076200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06076200, "Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06076200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*